🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

We have validated a novel method that discriminates reduced adherence from adherence to atorvastatin therapy with high diagnostic accuracy. The tool may contribute to improve lipid management. academic.oup.com/ehjcvp/advance… Jonas Pivoriunas Nils Tore Vethe @FagerlandWang #EHJCVP

In an exploratory case-control study atovastatin metabolites appear promising as biomarkers for the identification of clinical statin intolerance in patients with self-perceived statin side effects. sciencedirect.com/science/articl… Atherosclerosis Nils Tore Vethe

Availible AND accesseble! Nurse-led motivational interviewing combined with a proactive referral strategy increased access to smoking cessation treatment after hospitalization for atherosclerotic disease academic.oup.com/ehjopen/advanc… Karin Pleym Atferdsmedisin Vestre Viken

Long-term follow-up of CHD patients <80yrs ☑️ <70% on high-intensity statins, only 25% used ezetimibe ☑️ 22% had treatment gaps >180 days Major potential for improving lipid management after CHD events atherosclerosis-journal.com/article/S0021-… Vestre Viken Atferdsmedisin Oslo Economics Sigrun Halvorsen

Our #ESCPrev2024 Social Media Ambassadors and #ESCPrevmotions Team are ready😊 Everyone, have fun & enjoy the live coverage & videos Dr Anastasia Mihailidou FAHA FCSANZ FESC Francesco Perone Giuseppe Biondi-Zoccai Silvia Castelletti Andreas Gevaert Sabiha Gati EAPCPresident Vasiliki Tsampasian John Munkhaugen Buket Akıncı

“Young Ambassadors are representing EAPC Young Community in their respective countries”. A quick interview with the new Editor-in-chief prof. Victor Aboyans about his mission for the #EJPC. #ESCPrev2024 #ESCPrevmotions

… and the winner is Blue Team 🏆 👏 Join us in Milan in #ESCPrev2025 ! You may be the next winner of “Body&Mind Challenge” #ESCPrev2024 #ESCPrevmotions Vasiliki Tsampasian Sabiha Gati John Munkhaugen

🎤What has changed in 20 years in EAPC? A great interview with the Honorable President Prof. David Wood! #ESCPrev2024 #ESCPrevmotions Sabiha Gati Vasiliki Tsampasian John Munkhaugen European Society of Cardiology Svetlana Mosteoru

Excellent presentation by our PhD candidate Jonas Pivoriunas at #ESCPrev2024 ✅ statin adherence measured with our novel blood test strongly aligns with long-term adherence assessed by pharmacy registry. The blood test emerges as a promising tool for enhancing lipid management

Excellent presentation by our PhD candidate Trine Lauritzen at #ESCPrev2024 ✅ The first study evaluating mevalonate in blood and muscle as potential biomarker of statin intolerance Nils Tore Vethe Vestre Viken

Many thanks to the #ESC and the #EAPC to help us to spread the (scientific) news. I invite all my followers to follow my official account so to stay tuned about cardiovascular prevention !👇

Congratulations to our PhD candidate Ingrid Engebretsen on her fantastic presentation at #ESCCongress2024. Non-adherence to PCSk9i and oral LLT is a major challenge in Norway Atferdsmedisin Oslo Economics Vestre Viken Sigrun Halvorsen Kristina M. Ødegaard

Advance Care Planning is about to be implemented in Norwegian hospitals. This implementation process is part of a multi center study, and part one is just published in Tidsskriftet. Well done Hege Ihle-Hansen John Munkhaugen et. al tidsskriftet.no/en/2024/11/sho…

🚨 #ESCPrev2025 🚨 Make an impact in Milan, #ESCPrev2025 is coming! Submit your research today 💫🌟 🛑Abstract deadline: 21 Nov, 12:00 (noon) CET 🛑Clinical case deadline: 28 Nov, 12:00 (noon) CET International audience is waiting to hear about your latest scientific results ☕️

Kom og jobb sammen med oss - Spennede stilling som 1. amanuensis / professor innen atferdsmedisin ute nå! Del gjerne! UiO - Det medisinske fakultet Atferdsmedisin jobbnorge.no//ledige-stilli…

Thrilled to announce that we have received ~2mill EUR from Helse- og omsorgsdep to conduct the STRONG@HOME trial at 7 sites in 🇳🇴🎉. Building on #STRONGHF, this trial will test efficacy and safety of rapid uptitration of #GDMT after HF hosp can be performed by digital follow-up 📲

ESC Preventive Cardiology 2025 is coming! Haven't registered yet? 😮 Join us to discover the very latest science in preventive cardiology, hear inspiring speakers, learn about innovations changing practice and much more! See you in Milan? 🤩 #ESCPrev2025 European Society of Cardiology EAPCPresident

The European Society of Cardiology has developed a new standardized LOE grading system to evaluate the strength of evidence in their guidelines. Separate criteria for (1) therapy & prevention,and (2) diagnosis & prediction. Glad to be in the unique position to be involved in both docs! European Society of Cardiology Journals

Xavier Rosselló European Society of Cardiology European Society of Cardiology Journals Borja Ibanez Jesús Álvarez-García Prof Chris P Gale Javed Butler John Munkhaugen Dan Atar Gregg W. Stone MD rafavidalperez HU Son Espases IdISBa Hopefully our findings, which would be soon revealed alongside the results of the BETAMI-DANBLOCK trial, will contribute to a level of evidence A of future ACS guidelines! Borja Ibanez Sergio Raposeiras-Roubín JóvenesSEC CVCT - CardioVascular Clinical Trialists Faiez ZANNAD Gregg W. Stone MD Javed Butler Harriette Van Spall, MD MPH 🇨🇦

Dep. of Behavioural Med. has been evaluated by the Research Council of Norway: "This is an impressive research group that delivers in relation to its aims and objectives...It stands out for taking into account the complexity of biopsychosocial aspects of health and illness." 5/5